Evidence map›Paper›PMID 30244433›Full record

ArticlePurinergic signalling2018

Mononuclear-cell-derived microparticles attenuate endothelial inflammation by transfer of miR-142-3p in a CD39 dependent manner.

Stephanie Kuhn, Katrin Splith, Cindy Ballschuh, Linda Feldbrügge, Felix Krenzien, Georgi Atanasov, Christian Benzing, Hans-Michael Hau, Cornelius Engelmann, Thomas Berg and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Purinergic signalling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Extracellular Vesicles and Vascular Inflammation.Advances in experimental medicine and biology · 2023
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Stephanie KuhnDepartment of Environmental Immunology, Helmholtz Centre for Environmental Research GmbH - UFZ, Leipzig, Germany.
Katrin SplithDepartment of Surgery, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Cindy BallschuhDepartment of GMP Cell and Gene Therapy, Fraunhofer Institute for Cell Therapy and Immunology - IZI, Leipzig, Germany.
Linda FeldbrüggeDepartment of Surgery, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Felix KrenzienDepartment of Surgery, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Georgi AtanasovDepartment of Surgery, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Christian BenzingDepartment of Surgery, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Hans-Michael HauDepartment of Visceral, Transplant, Thoracic, and Vascular Surgery, University Hospital Leipzig, Leipzig, Germany.
Cornelius EngelmannDepartment of Medicine, Division of Hepatology, University Hospital of Leipzig, Leipzig, Germany.
Thomas BergDepartment of Medicine, Division of Hepatology, University Hospital of Leipzig, Leipzig, Germany.
Jan Schulte Am EschDepartment of General- and Visceral Surgery, Evangelical Hospital Bielefeld, Bielefeld, Germany.
Johann PratschkeDepartment of Surgery, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Simon C RobsonThe Transplant Institute and Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA, USA.
Moritz SchmelzleDepartment of Surgery, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany. moritz.schmelzle@charite.de.
Charité - Universitätsmedizin Berlin · DEUniversity Hospital Leipzig · DEBeth Israel Deaconess Medical Center · USEvangelisches Krankenhaus Bielefeld · DEFraunhofer Institute for Cell Therapy and Immunology · DEHelmholtz Centre for Environmental Research · DE

Funding

UPIT: Unleash the Potential of Intestinal TransplantationR01AI132389 · NIAID · GEORGETOWN UNIVERSITY · PI KROEMER, ALEXANDER HELMUT KURT · 2017 to 2021
$2.4M
Bundesministerium für Bildung und Forschung BMBF 1315883Deutsche Forschungsgemeinschaft DFG 2661/3-1NIAID NIH HHS R01 AI132389
6 · The paper itself

Abstract

Plasma microparticles (MP) bear functional active ectonucleotidases of the CD39 family with implications in vascular inflammation. MP appear to be able to fuse with cells and transfer genetic information. Here, we tested whether levels of different immunomodulatory microRNAs (miRs) in plasma MP are modulated by CD39 after experimental hepatectomy. We further investigated whether horizontal transfer of miR-142-3p between mononuclear (MNC) and endothelial cells via MP is regulated by purinergic signaling. Partial hepatectomy was performed in C57BL/6 wild type and Cd39 null mice. MP were collected via ultracentrifugation. MNC were stimulated with nucleotides and nucleosides, in vitro, and tested for miR-142-3p levels. Fusion of MNC-derived MP and endothelial cells with subsequent transfer of miR-142-3p was imaged by flow cytometry and confocal microscopy. Endothelial inflammation and apoptosis were quantified after transfection with miR-142-3p. Significantly lower miR-142-3p levels were observed in plasma MP of Cd39 null mice after partial hepatectomy, when compared to C57BL/6 wild types (p < 0.05). In contrast to extracellular nucleotides, anti-inflammatory adenosine significantly increased miR-142-3p levels in MNC-derived MP, in vitro (p < 0.05). MNC-derived MP are able to transfer miR-142-3p to endothelial cells by fusion. Transfection of endothelial cells with miR-142-3p decreased TNF-α levels (p < 0.05) and endothelial apoptosis (p < 0.05). MiR-142-3p levels in MNC-derived MP are modulated by nucleoside signaling and might reflect compensatory responses in vascular inflammation. Our data suggest the transfer of genetic information via shed MP as a putative mechanism of intercellular communication-with implications in organ regeneration.

Indexed as

AnimalsAntigens, CDApoptosisApyraseCell-Derived MicroparticlesCell ProliferationEndothelial CellsInflammationMice, Inbred C57BLMicroRNAsAntigens, CDApyraseCD39 antigenMicroRNAsMIRN142 microRNA, ratLiver regenerationMicroRNAMicrovesiclesPartial hepatectomyPurinergic signalingVascular inflammation

Identifiers

PMID30244433
PMCPMC6298922
OpenAlexW2893204004

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.